SCHEMBL9004777

SCHEMBL9004777

O=C(NN=c1c(=O)c2ccccc2c1=O)Nc1c(F)cccc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
SENP6 Q9GZR1 3/20 0.51
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
ALDH1A1 P00352 3/20 0.51
CASP3 P42574 2/20 0.51
SENP8 Q96LD8 2/20 0.51
SENP7 Q9BQF6 2/20 0.51
APAF1 O14727 1/20 0.51
TDP2 O95551 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
THRB P10828 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
MEN1 O00255 3/20 0.46
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004668 0.85 RAB9A (0.57) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL8664293 0.80 KMT2A (0.48) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL9004670 0.79 MAPT (0.55) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL9004624 0.79 RAB9A (0.50) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL8667830 0.78 SENP6 (0.61) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL9004783 0.78 RAB9A (0.55) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL9004616 0.77 MAPT (0.46) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL9232385 0.77 SENP6 (0.51) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL9004601 0.76 SMN1; SMN2 (0.48) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1
SCHEMBL8663571 0.76 RAB9A (0.45) KMT2ASENP6MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571843-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1996-11-05 US disclosed
EP-0566445-B1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566445-A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020045-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR THE PREPARATION OF SAME AND THEIR APPLICATION AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed